| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Xenon Pharmaceuticals Inc (NASDAQ: XENE)
XENE Technical Analysis
5
| As on 9th Jun 2023 XENE STOCK Price closed @ 42.02 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 32.61 & Strong Buy for SHORT-TERM with Stoploss of 30.00 we also expect STOCK to react on Following IMPORTANT LEVELS. |
XENESTOCK Price
| Open | 42.43 | Change | Price | % |
| High | 42.73 | 1 Day | -0.49 | -1.15 |
| Low | 41.92 | 1 Week | 3.49 | 9.06 |
| Close | 42.02 | 1 Month | 2.64 | 6.70 |
| Volume | 398100 | 1 Year | 12.57 | 42.68 |
| 52 Week High 43.54 | 52 Week Low 25.09 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| XENE Daily Charts |
XENE Intraday Charts |
Whats New @ Bazaartrend |
XENE Free Analysis |
|
|
XENE Important Levels Intraday
| RESISTANCE | 43.58 |
| RESISTANCE | 43.08 |
| RESISTANCE | 42.77 |
| RESISTANCE | 42.46 |
| SUPPORT | 41.58 |
| SUPPORT | 41.27 |
| SUPPORT | 40.96 |
| SUPPORT | 40.46 |
XENE Forecast April 2024
| 4th UP Forecast | 59.07 |
| 3rd UP Forecast | 53.6 |
| 2nd UP Forecast | 50.22 |
| 1st UP Forecast | 46.84 |
| 1st DOWN Forecast | 37.2 |
| 2nd DOWN Forecast | 33.82 |
| 3rd DOWN Forecast | 30.44 |
| 4th DOWN Forecast | 24.97 |
XENE Weekly Forecast
| 4th UP Forecast | 48.67 |
| 3rd UP Forecast | 46.54 |
| 2nd UP Forecast | 45.22 |
| 1st UP Forecast | 43.90 |
| 1st DOWN Forecast | 40.14 |
| 2nd DOWN Forecast | 38.82 |
| 3rd DOWN Forecast | 37.50 |
| 4th DOWN Forecast | 35.37 |
XENE Forecast2024
| 4th UP Forecast | 78.58 |
| 3rd UP Forecast | 66.85 |
| 2nd UP Forecast | 59.61 |
| 1st UP Forecast | 52.36 |
| 1st DOWN Forecast | 31.68 |
| 2nd DOWN Forecast | 24.43 |
| 3rd DOWN Forecast | 17.19 |
| 4th DOWN Forecast | 5.46 |
Xenon Pharmaceuticals Inc ( NASDAQ USA Symbol : XENE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
XENE Business Profile
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel modulator that is Phase III clinical trials for the treatment of KCNQ2 epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel modulator, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop FX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. The company was incorporated in 1996 and is headquartered in Burnaby, Canada. Address: 200-3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service